We are live on
!
Find out more
BRA
Bender Robert & Associates Portfolio holdings
AUM
$481M
1-Year Est. Return
35.73%
This Fund
S&P 500
This Quarter
Est. Return
+8.25%
1 Year Est. Return
+35.73%
3 Year Est. Return
+116.09%
5 Year Est. Return
+167.64%
10 Year Est. Return
+1,066.43%
AUM
$347M
AUM Growth
-$2.81M
(-0.8%)
Cap. Flow
-$24.6M
Cap. Flow
% of AUM
-7.11%
Top 10 Holdings %
Top 10 Hldgs %
73.11%
Holding
49
New
–
Increased
–
Reduced
1
Closed
3
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuitive Surgical
ISRG
|
+$21.8M |
| 2 |
Protolabs
PRLB
|
+$1.36M |
| 3 |
Exelixis
EXEL
|
+$1.24M |
| 4 |
Honeywell
HON
|
+$212K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.64% |
| 2 | Consumer Discretionary | 30.16% |
| 3 | Healthcare | 21.1% |
| 4 | Communication Services | 12.66% |
| 5 | Utilities | 0.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
NextEra Energy
NEE
$171B
| $2.74M | 0.79% |
34,908
| – | – |
|
27
Eli Lilly
LLY
$1.02T
| $2.09M | 0.6% |
9,044
| – | – |
|
28
Advanced Micro Devices
AMD
$812B
| $1.37M | 0.4% |
13,308
| – | – |
|
29
Abbott
ABT
$178B
| $1.06M | 0.31% |
8,976
| – | – |
|
30
Bristol-Myers Squibb
BMY
$131B
| $913K | 0.26% |
15,425
| – | – |
|
31
Norfolk Southern
NSC
$72B
| $860K | 0.25% |
3,595
| – | – |
|
32
Costco
COST
$407B
| $846K | 0.24% |
1,883
| – | – |
|
33
Boeing
BA
$165B
| $838K | 0.24% |
3,809
| – | – |
|
34
Johnson & Johnson
JNJ
$645B
| $805K | 0.23% |
4,986
| – | – |
|
35
JPMorgan Chase
JPM
$930B
| $697K | 0.2% |
4,261
| – | – |
|
36
Pfizer
PFE
$158B
| $577K | 0.17% |
13,417
| – | – |
|
37
Paychex
PAYX
$42.1B
| $541K | 0.16% |
4,810
| – | – |
|
38
T. Rowe Price
TROW
$22.5B
| $491K | 0.14% |
2,495
| – | – |
|
39
Target
TGT
$72.3B
| $490K | 0.14% |
2,140
| – | – |
|
40
Merck
MRK
$358B
| $484K | 0.14% |
6,442
| – | – |
|
41
Deere & Co
DE
$183B
| $472K | 0.14% |
1,410
| – | – |
|
42
Nucor
NUE
$57.6B
| $431K | 0.12% |
4,375
| – | – |
|
43
Caterpillar
CAT
$362B
| $326K | 0.09% |
1,697
| – | – |
|
44
Idexx Laboratories
IDXX
$40B
| $314K | 0.09% |
505
| – | – |
|
45
Duke Energy
DUK
$92.9B
| $256K | 0.07% |
2,626
| – | – |
|
46
ServiceNow
NOW
$147B
| $252K | 0.07% |
2,025
| – | – |
|
|
47
Exelixis
EXEL
$14B
| – | – |
-58,469
| Closed | -$1.24M |
|
|
48
Honeywell
HON
$63.1B
| – | – |
-1,061
| Closed | -$212K |
|
|
49
Protolabs
PRLB
$1.89B
| – | – |
-20,385
| Closed | -$1.36M |
|
Similar funds
MA
WAS
SA
NC
HWMG
MAV
OMIC
SCA
Bender Robert & Associates's Q4 2021 Portfolio in Review
As of Q4 2021, Bender Robert & Associates held 49 positions worth $347M, down 0.8% from $349M the previous quarter. Its ten largest holdings account for 73% of the portfolio.
Bender Robert & Associates withdrew a net $24.6M in Q4 2021, closing 3 positions and reducing 1 holding. Its most notable exit was Protolabs, an estimated $1.36M position sold in full.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 33% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Bender Robert & Associates's biggest Q4 2021 reduction was Intuitive Surgical, cutting an estimated $21.8M.
- Bender Robert & Associates fully exited Protolabs in Q4 2021, selling an estimated $1.36M.
- Bender Robert & Associates's ten largest holdings make up 73% of its $347M portfolio in Q4 2021.
- Bender Robert & Associates opened 0 new positions and closed 3 in Q4 2021.
- Bender Robert & Associates's portfolio value fell 0.8% quarter-over-quarter to $347M.
Based on Bender Robert & Associates's 13F filing for Q4 2021, filed 7 Feb 2022.